<li>Hussein A. Tawbi, Dirk Schadendorf, Evan J. Lipson, Paolo A. Ascierto, Luis Matamala, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen J. Gogas, Christopher D. Lao, Juliana Janoski De Menezes, Stéphane Dalle, Ana Arance, Jean-Jacques Grob, Shivani Srivastava, Mena Abaskharoun, Melissa Hamilton, Sarah Keidel, Katy L. Simonsen, Anne Marie Sobiesk, Bin Li, F. Stephen Hodi, Georgina V. Long. <strong>Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma</strong>. <em>New England Journal of Medicine</em>, 2022; 386 (1): 24 DOI: <a href="http://dx.doi.org/10.1056/NEJMoa2109970" rel="nofollow" target="_blank">10.1056/NEJMoa2109970</a>
</li>